Study to compare "levobupivacaine with dexmeditomidine " and "levobupivacaine with dexamethasone " in caudal block for postoperative analgesia

A Comparative study of levobupivacaine 0.25% with dexmeditomidine and dexamethasone as adjuvant in caudal block for paediatric patients undergoing infraumbilical surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056787

Enrollment

Registered

2023-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N430- Encysted hydrocele Health Condition 2: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Levobupivacaine: 0.25% Levobupivacaine 1ml/kg in caudal block in children undergoing infraumbilical surgeries within 6months of duration Control Intervention1: Dexmeditomidine: 1ug/kg D

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing infraumbilical surgeries Parents or guardian giving consent to participate in study of age between 1year to 8years of ASA Grade I and II

Exclusion criteria

Exclusion criteria: Patients guardian not giving consent to participate in the study ASA Grade III and IV Patients with known hypersenstivity to local anaesthestics Abnormal coagulopathy Preexisting neurological disease Local sepsis or infection Mentally retarded child Abnormal sacral anatomy

Design outcomes

Primary

Measure	Time frame
Its Expected that moderate dose of caudal analgesia with 0.25% levobupivacaine 1ml/kg with dexmeditomidine is more effective than 0.25% levobupivacaine 1ml/kg with dexamethasoneTimepoint: 24hours	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR Batula Shravani

Gajra raja medical college gwalior

dr.neelimatandon21@gmail.com7013843124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026